Making a poison pill easier to swallow: How to manage M&A-related software licensing costs and compliance risks has been saved
Perspectives
Making a poison pill easier to swallow: How to manage M&A-related software licensing costs and compliance risks
Part of the #Tech @ the heart of M&A series
“Making a ‘poison pill’ easier to swallow: How to manage M&A-related software licensing costs and compliance risks” cautions that mismanaging an M&A-based software re-contracting effort may result in noncompliance, penalties, transfer fees, and duplicate licensing. An antidote to the “poison pill” can be a highly regimented, centralized, streamlined approach to software re-contracting.
About the #Tech @ the heart of M&A series
In a new series on the role of technology in M&A, #Tech @ the heart of M&A, Deloitte provides a comprehensive overview of M&A technology transformation based on helping clients with the essential steps—from cost management to contract separation through application elements of privacy protection and service delivery components of infrastructure. By providing the building blocks for a clearly articulated, defined, and institution-wide approach to M&A technology implementation, Deloitte clients can free up technology executives for the more important and highest value-add role they can play in the M&A transaction—driving the core technology strategy in tandem with revenue growth and cost-curve optimization.
Meet the authors
For more information on this topic, please contact:
Thomas Jackson, principal, Deloitte Consulting LLP
Joni Young, director, Deloitte Consulting LLP
